| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 726.77 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Uveíte, é o termo utilizado para definir a inflamação do trato uveal. A uveíte tem uma
prevalência de 1/4500 na população geral. Estima-se que seja responsável por 5-20% dos casos
de perda visual nos EUA, 3 a 7% em países europeus e de 3 a 10% em países em desenvolvimento.
O tratamento da uveíte faz-se a maior parte das vezes através de corticóides, cicloplégicos
midriáticos, imunossupressores, agentes não-esteróides anti-inflamatórios efotocoagulação.
A pressão intraocular elevada é uma complicação frequente da inflamação intraocular,
afetando de 5 a 19% dos pacientes com uveíte. A pressão intraocular elevada pode ser aguda
ou crônica e ambas podem levar a defeitos no campo visual no glaucoma secundário à uveíte
hipertensiva.
Neste relatório, descrevemos um caso de uma uveíte hipertensiva após complicação de
uma facoemulsificação, numa paciente de 48 anos. A terapêutica teve como fase inicial o
tratamento da uveíte e diminuição da pressão intraocular, seguindo-se a recolocação da lente
intraocular.
Uveitis is the term used to define inflammation of the uveal tract. Uveitis has a prevalence of 1/4500 in the general population. It is estimated to be responsible for 5-20% of visual loss cases in the US, 3 to 7% in European countries and 3 to 10% in developing countries. The treatment of uveitis is most often through corticoids, mydriastic cycloplegics, immunosuppressants, non-steroidal anti-inflammatory agents and photocoagulation. Elevated intraocular pressure is a frequent complication of intraocular inflammation, affecting 5 to 19% of patients with uveitis. Elevated intraocular pressure could be acute or chronic and both could lead to visual field defects in glaucoma secondary to hypertensive uveitis. In this report, we describe a case of a hypertensive uveitis after a complication of phacoemulsification in a 48 year old patient. Therapy was initially treated with uveitis and decreased intraocular pressure, followed by intraocular lens replacement.
Uveitis is the term used to define inflammation of the uveal tract. Uveitis has a prevalence of 1/4500 in the general population. It is estimated to be responsible for 5-20% of visual loss cases in the US, 3 to 7% in European countries and 3 to 10% in developing countries. The treatment of uveitis is most often through corticoids, mydriastic cycloplegics, immunosuppressants, non-steroidal anti-inflammatory agents and photocoagulation. Elevated intraocular pressure is a frequent complication of intraocular inflammation, affecting 5 to 19% of patients with uveitis. Elevated intraocular pressure could be acute or chronic and both could lead to visual field defects in glaucoma secondary to hypertensive uveitis. In this report, we describe a case of a hypertensive uveitis after a complication of phacoemulsification in a 48 year old patient. Therapy was initially treated with uveitis and decreased intraocular pressure, followed by intraocular lens replacement.
Description
Keywords
Crescimento Económico Desenvolvimento Financeiro Globalização Painel Ardl